Topotecan Hydrochloride - NDC drug/product
NDCs and labelers of "Topotecan Hydrochloride":
NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
---|---|---|---|---|
16729-0151 | topotecan hydrochloride | Accord Healthcare, Inc. | NO | |
45963-0615 | Topotecan hydrochloride | Actavis Pharma, Inc. | NO | |
55390-0370 | Topotecan Hydrochloride | Bedford Laboratories | YES | No later than 2024-03-26 |
69097-0262 | TOPOTECAN HYDROCHLORIDE | Cipla USA Inc. | YES | No later than 2022-12-30 |
63323-0762 | Topotecan Hydrochloride | Fresenius Kabi USA, LLC | NO | |
67457-0474 | TOPOTECAN HYDROCHLORIDE | Mylan Institutional LLC | YES | No later than 2018-03-29 |
00069-0075 | Topotecan Hydrochloride | Pfizer Laboratories Div Pfizer Inc. | YES | No later than 2018-06-28 |
25021-0206 | Topotecan Hydrochloride | Sagent Pharmaceuticals | YES | No later than 2019-03-18 |
25021-0824 | Topotecan Hydrochloride | Sagent Pharmaceuticals | YES | No later than 2019-03-18 |
62756-0023 | Topotecan hydrochloride | Sun Pharmaceutical Industries Limited | YES | No later than 2017-04-03 |
66435-0410 | Topotecan Hydrochloride | Three Rivers Pharmaceuticals, LLC. | YES | No later than 2018-06-28 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.